---
title: "Bristol-Myers Squibb (BMY) Gets a Hold from Erste Group"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281576159.md"
description: "Erste Group analyst has maintained a Hold rating on Bristol-Myers Squibb (BMY), with shares closing at $61.73. The overall analyst consensus suggests a Moderate Buy rating with an average price target of $62.67, indicating a potential upside of 1.52%. Additionally, Wells Fargo also assigned a Hold rating with a price target of $60.00."
datetime: "2026-04-02T20:05:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281576159.md)
  - [en](https://longbridge.com/en/news/281576159.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281576159.md)
---

# Bristol-Myers Squibb (BMY) Gets a Hold from Erste Group

Erste Group analyst maintained a Hold rating on Bristol-Myers Squibb yesterday. The company’s shares closed today at $61.73.

### End of Quarter Sale - 50% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Bristol-Myers Squibb with a $62.67 average price target, a 1.52% upside from current levels. In a report released today, Wells Fargo also assigned a Hold rating to the stock with a $60.00 price target.

### Related Stocks

- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [RXL.US](https://longbridge.com/en/quote/RXL.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [PILL.US](https://longbridge.com/en/quote/PILL.US.md)

## Related News & Research

- [North Dakota State Investment Board Boosts Holdings in Bristol Myers Squibb Company $BMY](https://longbridge.com/en/news/296020226.md)
- [FDA grants accelerated approval to Bristol Myers Squibb’s ZENBEXUS for relapsed multiple myeloma combo use](https://longbridge.com/en/news/295848217.md)
- [Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene](https://longbridge.com/en/news/296131073.md)
- [Bristol Myers Squibb Gets FDA Nod For Novel Multiple Myeloma Treatment](https://longbridge.com/en/news/295957550.md)
- [Heart drug developer Atrium Therapeutics' Q2 loss widens as expenses rise](https://longbridge.com/en/news/295851809.md)